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Abstract
Background: Hepatitis B virus (HBV) infection causes large amount of unfolding or false-folding protein accumulation 
in the endoplasmic reticulum (ER), which in turn induces the expression of glucose-regulated protein 78 (GRP78). The 
aim in the present study was to analyse the potential association between GRP78 single-nucleotide polymorphisms 
(SNPs) and the risk of HBV infection.
Methods: The associations between seven common GRP78 polymorphisms in the promoter (rs391957, rs17840762, 
rs17840761, rs11355458) and in the 3' untranslated region (UTR) (rs16927997, rs1140763, rs12009) and possible risk of 
chronic HBV infection were assessed in a case-control study. 496 cases and 539 individually matched healthy controls 
were genotyped.
Results: Overall, no associations were observed in genotypic analyses. In addition, haplotypes and diplotypes 
combining those SNPs in the promoter or in the 3' UTR in high linkage disequilibrium (LD) were also not associated 
with HBV risk.
Conclusion: These observations do not support a role for GRP78 polymorphisms in HBV infection in a predominantly 
Chinese Han population.
Background
Hepatitis B virus (HBV) infection is one of the major
infectious diseases that may lead to chronic liver disease,
cirrhosis, and hepatocellular carcinoma (HCC) [1].
Approximately 30% of the world's population has been
infected with HBV and approximately 350 million are
persistent carriers. The mechanisms underlying resolu-
tion of acute HBV infection or its progression to chronic-
ity remain undetermined [2]. Approximately 90% of
infants infected from HBV e antigen (HBeAg) positive
mothers will fail to achieve clearance and develop persis-
tent HBV infection. Whereas, for adults, the majority of
HBV-infected individuals achieve clearance with just less
than 10% becoming persistent carriers[3].
Glucose-regulated protein 78 (GRP78), also recognized
as immunoglobulin heavy-chain binding protein (BiP) as
it was found bound to immunoglobulin heavy chains in
pre-B cells, is known to be induced in the endoplasmic
reticulum (ER) compartment by a variety of stresses [4].
These stress signals include glucose starvation, ER Ca2+
depletion, virus infection or cancer progress which leads
to accumulation of misfolded proteins in the ER. It has
been shown that GRP78 functions as an antiapoptotic
chaperone playing a key role in maintaining the proper
functions of proteins and organelles [5].
Recent studies have emphasized that GRP78  play
important roles in the progression inhibition of chronic
HBV infection and HCC progression [6,7]. Overexpres-
sion of the large superficial protein of HBV which trans-
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lated from transcripts specified by a preS1 promoter in
Huh7 cells results in a blockage of secretion of hepatitis B
surface antigen (HBsAg), which leads to an accumulation
of HBsAg in the ER lumen and in turn induces expression
of GRP78[8]. The presence of pre-S mutants of HBV in
sera and tissues was related to a high risk of developing
HCC, and subsequently induce ER stress, leading to the
expression of GRP78 [9-11].
In the previous projects, we focused on the possible
association between HBV infection or HCC risk/progno-
sis and GRP78 polymorphism involving a new mutation
(-87 T>A, from the estimated translation start site of
GRP78 gene), or an intronic mutation (rs430397 G>A, in
the intron 5 of GRP78 gene). These studies indicated that
GRP78  was associated with HCC progression, but not
associated with HBV infection [12,13]. As a part of series
of studies about relationship of polymorphism(s) and
stress-associated diseases, we hypothesized that poly-
morphisms in promoter and 3' untranslated region
(UTR), which were known to be involved in regulation of
gene expression, may be contributing factors or markers
of a stress-associated disease, such as virus infection. To
test this possibility, we further compared GRP78 poly-
morphisms at seven common loci in the promoter region
(rs391957, rs17840762, rs17840761, rs11355458) and the
3' UTR (rs16927997, rs1140763, rs12009) between
chronic HBV carriers and healthy subjects, and to reveal
the possible association between HBV infection and
GRP78 gene.
Methods
Subjects
496 Han patients with chronic HBV infection as case
series who had been treated as inpatients or outpatients
were enrolled in several affiliated hospitals of Guangzhou
Medical College between January 2001 and April 2005.
The diagnosis of chronic HBV infection was based on the
presence of HBsAg and HBeAg, or HBsAg and anti-HBe,
together with the absence of anti-HBs, for at least 36
months (according to the corresponding inpatient and
outpatient records) prior to enrolment. All these were
tested to exclude hepatitis C virus (HCV) or human
immunodeficiency virus (HIV) infection, the presence of
autoimmune hepatitis, and/or alcohol consumption
exceeding 8 g per day and other conspicuous diseases.
Patients who received antiviral therapy including inter-
feron or nucleoside analogues within one year of enroll-
ment were also excluded.
539 unrelated healthy HBV non-infected controls were
recruited from Han volunteer blood donors in above hos-
pitals and the Department of Cancer, Zhongshan School
of Medicine in Sun Yat-sen University in the same time.
T h e  c o n t r o l s  w e r e  n e g a t i v e  f o r  H B s A g ,  a n t i - H B s  a n d
anti-HBc, with normal serum alanine aminotransferase
(ALT) levels. These subjects were members of the health-
care staff of the hospitals who were periodically moni-
tored for professional exposure to hepatitis viruses. A
standard informed consent, was given to the participants,
after the nature of study had been fully explained. The
study was performed with the approval of the ethical
committee of Guangzhou Medical College and adhered
to the tenets of the Declaration of Helsinki.
Genotyping
Genomic DNA was extracted from peripheral blood leu-
kocytes using QIAGEN QIAamp DNA Mini Blood Kit
(Hilden, Germany). The SNPs were detected by the Taq-
Man Assay-by-Design service (Applied Biosystems, Fos-
ter City, CA). The details of sequences and reaction
conditions are available upon request https://prod-
ucts.appliedbiosystems.com/ab/en/US/adirect/ab. PCR
was performed using the TaqMan Universal Master Mix
without UNG on the ABI PRISM 7900 HT Sequence
Detection System (Applied Biosystems, Foster City, CA)
and heated to 95°C for 10 minutes followed by 40 cycles
of 92°C for 15 seconds and 60°C for 1 minute.
Haplotype and diplotype construction
Haplotype frequencies and pairwise linkage disequilib-
rium (LD) matrices were determined using the Haplo-
view version 3.2.0 (Whitehead Institute for Biomedical
Research, USA)[14]. Magnitudes of LD were represented
by the standardized LD coefficients, complete association
(D') and absolute association (r2) [15-17]. The frequencies
closely agreed with results from a maximum likelihood
method implemented via an expectation-maximization
(EM) algorithm[18]. Haplotypes and diplotypes were
selected according to the corresponding occurring proba-
bilities with a higher likelihood (> 0.95 as cut-point) [19].
Table 1: Characterization of the participants
Characteristics Cases (%) Controls (%) P
n4 9 6 5 3 9
Age (mean ± SD) 41.9 ± 13.5 43.0 ± 9.7 0.130a
Gender
Females 193 (38.91) 232 (43.04)
Males 303 (61.09) 307 (56.96) 0.177b
ALT (U/L, means ± SD) 147.1 ± 95.5 26.7 ± 11.4 0.008a
HBsAg (+) 496 (100%) 0
anti-HBs (+) 0 0
HBeAg (+) 193 (38.91) 0
anti-HBe (+) 303 (61.09) 0
Abbreviations: SD, standard deviation; ALT, alanine 
aminotransferase.
aMann-Whitney test; bPearson Chi-square test.Zhu et al. BMC Medical Genetics 2010, 11:83
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Statistical analysis
Chi-square test was used to determine whether there is a
significant difference between cases and controls in terms
of gender. Mann-Whitney U-test was used to test the dif-
ference among the age groups. Hardy-Weinberg equilib-
rium (HWE) of genotype distribution among cases or
controls was carried out using Pearson Chi-square test.
Logistic regression analysis was used to estimate odds
ratios (ORs) and corresponding 95% confidence intervals
(CIs) comparing cases to controls in association with
genotypes, haplotypes and diplotypes using dominant,
recessive and co-dominant models, respectively, adjusted
for age and sex. All statistical tests were 2-sided and sta-
tistical significance was taken as P value less than 0.05.
Results
In the cases, the age at diagnosis ranged 25.5-59.8 years,
the mean age was 41.9 (± 13.5) years, and the gender
(male/female) ratio was 1.57:1. In the controls, the age
ranged 27.0-56.2 years, the mean age was 43.0 (± 9.7)
years, and the gender ratio was 1.32:1. The cases and the
controls were frequency-matched by age (± 5 years, p =
0.130) and gender (p = 0.177), but not by serum ALT lev-
els (p = 0.008) (Table 1).
Genotyping data for each single-nucleotide polymor-
phism (SNP) were successfully obtained for 100% of the
subjects. The distribution of the genotypes in controls
and cases did not deviate from that expected by Hardy-
Weinberg equilibrium (data not shown). Table 2 showed
Table 2: Genotype frequencies of GRP78 among cases and controls, and risk of HBV
Loci Genotypes Cases (%) Controls (%) OR (95% CI) P
rs391957 GG 275 (54.95) 320 (59.22) 1
AG 198 (40.00) 200 (37.24) 1.22 (0.94-1.59) 0.137
AA 23 (5.05) 19 (3.54) 1.60 (0.84-3.07) 0.354
p-trenda 0.106
rs17840762 CC 334 (67.39) 366 (67.97) 1
CT 144 (29.19) 151 (27.93) 1.05 (0.79-1.39) 0.659
TT 18 (3.42) 22 (4.10) 0.78 (0.41-1.51) 0.271
p-trenda 0.501
rs17840761 TT 130 (25.76) 156 (28.86) 1
CT 236 (47.74) 249 (46.37) 1.17 (0.87-1.59) 0.405
CC 130 (26.48) 134 (24.77) 1.24 (0.88-1.75) 0.222
p-trenda 0.245
rs11355458 d d 275 (54.95) 320 (59.22) 1
d G 198 (40.00) 200 (37.24) 1.22 (0.94-1.59) 0.137
GG 23 (5.05) 19 (3.54) 1.60 (0.84-3.07) 0.354
p-trenda 0.106
rs16927997 TT 440 (88.83) 480 (89.01) 1
CT 52 (10.45) 55 (10.24) 1.01 (0.67-1.53) 0.812
CC 4 (0.72) 4 (0.74) 1.04 (0.23-4.68) 0.460
p-trenda 0.393
rs1140763 TT 129 (25.40) 168 (31.10) 1
CT 236 (48.29) 246 (45.62) 1.36 (0.92-1.79) 0.348
CC 131 (26.31) 125 (23.28) 1.51 (0.95-2.06) 0.177
p-trenda 0.204
rs12009 TT 166 (31.61) 204 (37.80) 1
CT 222 (45.59) 237 (43.95) 1.25 (0.88-1.61) 0.291
CC 108 (21.80) 98 (18.25) 1.53 (0.96-2.08) 0.097
p-trenda 0.082
Note: OR, odds ratio; d, delete base.
aTest for trend of odds was two sided and was based on likelihood ratio tests assuming a multiplicative model for all cases.Zhu et al. BMC Medical Genetics 2010, 11:83
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the distribution of genotypic frequencies of the 7 SNPs in
chronic HBV patients and control subjects. No statisti-
cally significant differences were found between cases
and controls in any of the dominant, codominant or
recessive genotype models as well as the presence of sin-
gle variant alleles (p-trend > 0.05, respectively).
LD reflects the non random association of alleles at two
or more loci. Pair-wise LD analysis in 439 chronic HBV
carriers showed the two blocks (block 1, promoter,
including rs391957, rs17840762, rs17840761 and
rs11355458; Block 2, 3' UTR, including rs16927997,
rs1140763 and rs12009) which are designed according to
the internally developed solid spine of LD (Figure 1).
Rs391957 and rs11355458 were completely linked (r2 =
1.00) and rs1140763 and rs12009 were in high linkage dis-
equilibrium (r2 = 0.785) in these carriers.
Because genetic effects are not exerted individually, we
considered the combined effects of the all SNPs in this
study according to the LD. There are 4 haplotypes and 9
diplotypes in the promoter region, and 3 haplotypes and
6 diplotypes in the 3' UTR were constructed based on the
7 SNPs with minor allelic frequencies of above 1% in the
chronic HBV carriers. The distributions of haplotypes
and diplotypes exhibited no significant differences from
the risk of HBV infection (p-trend > 0.05, respectively,
Table 3 and Table 4).
Discussion
This was one of the series of studies to investigate the
association between GRP78 polymorphisms and risk of
HBV infection. In this case-control study, there were no
significant differences in risk of HBV associated with
SNPs at any of these loci in the promoter and the 3' UTR
of  GRP78  gene. A single SNP usually provides a little
information. If more SNPs are unified to construct haplo-
types and diplotypes, they would supply more informa-
tion and make up for short-coming of single SNP [20-22].
The SNPs identified in this study comprised 4 haplotypes
Figure 1 Linkage disequilibrium (LD) pattern (r2 plots) of the 
SNPs in the promoter and 3' UTR of GRP78 gene among the 496 
chronic HBV carriers, as generated by Haploview v3.2. Coding ex-
ons are marked by shaded blocks. The blocks are designed according 
to the internally developed solid spine of LD. The value within each di-
amond represents the pairwise correlation between pairs of SNPs 
(measured as 100 × r2) defined by the upper left and the upper right 
sides of the diamond. The diamond without a number corresponds to 
r2 = 1.
Table 3: Haplotype frequencies in the promoter region and the 3' UTR of GRP78 gene in HBV carriers and controls, and risk of HBV
Haplotypes Cases (%) Controls (%) OR (95% CI) P
Promoter
G-C-T-d 496 (49.64) 561 (51.96) 1
A-C-C-G 244 (25.04) 238 (22.16) 1.26 (0.92-1.58) 0.107
G-T-C-d 180 (18.02) 195 (18.08) 1.05 (0.80-1.35) 0.376
G-C-C-d 72 (7.30) 84 (7.82) 0.95 (0.71-1.32) 0.552
p-trenda 0.247
3' UTR
T-T-T 494 (49.55) 582 (53.91) 1
T-C-C 438 (44.50) 433 (40.22) 1.15 (0.87-1.46) 0.269
C-C-T 60 (5.95) 63 (5.87) 1.21 (0.76-1.65) 0.122
p-trenda 0.181
Note: OR, odds ratio, d, delete base.
aTest for trend of odds was two sided and was based on likelihood ratio tests assuming a multiplicative model for all cases.Zhu et al. BMC Medical Genetics 2010, 11:83
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and 9 diplotypes in the promoter region, and 3 haplo-
types and 6 diplotypes in the 3' UTR. By analyzing the
associations between haplotypes/diplotypes and chronic
HBV infection, however, no association were found.
The GRP78 promoter contains three ER stress response
elements (ERSEs) consisting of a tripartite structure
CCAATN9CCACG, with N being 9-bp GC-rich region
[23]. The four SNPs examined located not within but
upstream of ERSE. GRP78  promoter haplotypes may
affect the individual variability of ER stress response and
has been reported to be a potential risk factor for bipolar
disorder in a Japanese population [24]. These suggested
that the promoter haplotypes in the GRP78 gene were
significantly associated with the functional SNPs, which
were involved in the promoter activity. However, our
study did not demonstrate an association between the
promoter haplotypes and diplotypes with chronic HBV
infection in our Chinese population.
The rs16927997 is located next to the ATTTA motif
and substitution from T to C reduces the contents of AT.
Around the rs16927997, there are four ATTTA motifs
with AT-rich contents, which suggest that the region is
so-called "AU-rich element". Although AU-rich element
is associated with mRNA unstability and promotes degra-
dation of mRNA in most cases [25,26], significant differ-
ence was not observed between rs16927997-T and
rs16927997-C in a mRNA degradation assay [24]. The
present study further suggested that the alleles and geno-
types of rs16927997, rs1140763 and rs12009 in the 3'
UTR of GRP78 gene, including the corresponding haplo-
types and diplotypes, were not associated with the risk of
chronic HBV infection.
A number of contingent environmental conditions,
among which infectious diseases may have been the most
powerful, have exerted variable pressures on the human
genome and favored the selection of alleles interfering
with disease physiopathology. GRP78 has recently
emerged as an intracellular antiviral factor against HBV
[6]. HBV invasion and other physiopathologic changes
cause large amount of unfolding or false-folding protein
accumulation in the ER, which in turn induces expression
of GRP78 [27]. GRP78 pathway was one of the most
important responders to virus-associated stress [28,29].
But the mechanism was controversial. Possibly, GRP78
enhance primary immune protection against HBV. But its
polymorphisms do not play more important roles during
the chronic inflammation process. However, additional
studies from larger populations among Han Chinese, and
from diverse ethnic populations, are warranted before the
Table 4: Diplotype frequencies in the promoter region and the 3' UTR of GRP78 gene in HBV carriers and controls, and risk of HBV
Diplotypes Cases (%) Controls (%) OR (95% CI) p
Promoter
GCTd/GCTd 130 (25.77) 156 (28.86) 1
ACCG/GCTd 123 (24.86) 128 (23.84) 1.20 (0.83-1.76) 0.196
GCTd/GTCd 75 (15.14) 81 (14.90) 1.11 (0.74-1.65) 0.153
ACCG/GTCd 55 (11.17) 49 (9.12) 1.57 (0.97-2.55) 0.462
GCCd/GCTd 38 (7.75) 40 (7.45) 1.19 (0.72-2.07) 0.259
ACCG/GCCd 20 (3.96) 23 (4.28) 1.04 (0.53-2.00) 0.754
GTCd/GTCd 18 (3.42) 22 (4.10) 0.89 (0.45-1.75) 0.410
GCCd/GTCd 14 (2.88) 21 (3.91) 0.84 (0.41-1.72) 0.388
ACCG/ACCG 23 (5.05) 19 (3.54) 1.66 (0.85-3.24) 0.071
p-trenda 0.142
3' UTR
TCC/TTT 203 (41.62) 214 (39.66) 1
TTT/TTT 129 (25.41) 168 (31.10) 1.30 (0.95-1.80) 0.249
TCC/TCC 108 (21.80) 98 (18.25) 1.50 (0.75-2.28) 0.166
CCT/TTT 33 (6.67) 32 (5.96) 1.43 (0.82-2.46) 0.215
CCT/TCC 19 (3.78) 23 (4.28) 0.97 (0.55-2.13) 0.647
CCT/CCT 4 (0.72) 4 (0.74) 1.36 (0.26-6.08) 0.076
p-trenda 0.091
Note: OR, odds ratio; d, delete base.
aTest for trend of odds was two sided and was based on likelihood ratio tests assuming a multiplicative model for all cases.Zhu et al. BMC Medical Genetics 2010, 11:83
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importance of GRP78  polymorphisms in chronic HBV
risk can be fully ascertained.
Conclusion
In conclusion, the present study suggests that the GRP78
polymorphisms are not associated with chronic HBV
infection. These data, however, do not exclude a possible
physiopathological role of these SNPs in the progression
of chronic HBV infection.
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